Virbac SA (VIRP.PA) stock: key figures, P/E, revenue and dividend

Health Care · France · ISIN FR0000031577

Price
350.00 EUR
Market cap
2.93 bn EUR
P/E (2025)
19.51
P/S (2025)
2.00
Dividend yield
0.41 %
Net margin
10.25 %
Return on equity (ROE)
13.33 %
Return on assets (ROA)
7.84 %

Virbac SA financials

Fiscal year20242025
Revenue1.40 bn EUR1.46 bn EUR
Gross profit937.00 m EUR517.00 m EUR
Operating income229.03 m EUR230.15 m EUR
EBIT217.00 m EUR216.00 m EUR
Net income145.00 m EUR150.00 m EUR
Diluted EPS – continuing operations17.34 EUR17.94 EUR

Full history since 1997, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Virbac SA

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx soft chews formulated with ursolic acid that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, immunology, nutrition, petfood, and pharmaceutical products. In addition, the company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.